Gallbladder cancer

Signs and symptoms

• Steady pain in the upper right abdomen
• Indigestion (dyspepsia)
• Bilious vomit
• Weakness
• Loss of appetite
• Weight loss
• Jaundice and vomiting due to obstruction

Early symptoms mimic gallbladder inflammation due to gallstones. Later, the symptoms may be that of biliary and stomach obstruction.

Of note, Courvoisier's law states that in the presence of a palpably enlarged gallbladder which is nontender and accompanied with mild painless jaundice, the cause is unlikely to be gallstones. This implicates possible malignancy of the gallbladder or pancreas, and the swelling is unlikely due to gallstones due to the chronic inflammation associated with gallstones leading to a shrunken, non-distensible gallbladder. However, the original observations of Ludwig Georg Courvoisier, published in Germany in 1890, were not originally cited as a law, and no mention of malignancy or pain (tenderness) was made. These points are commonly misquoted or confused in the medical literature.

Risk factors

• Gender— it is approximately twice as common in women than men and presents commonly in seventh and eighth decades
• Obesity
• Chronic cholecystitis and cholelithiasis
• Primary sclerosing cholangitis
• Chronic typhoid infection of gallbladder; chronic Salmonella typhi carriers have 3 to 200 times higher risk of gallbladder cancer than non-carriers and 1–6% lifetime risk of development of cancer
• Various single nucleotide polymorphisms (SNPs) have been shown to be associated with gallbladder cancer; however, existing genetic studies in GBC susceptibility have so far been insufficient to confirm any association
• Gallbladder polyps
• Calcified gallbladder wall (porcelain gallbladder)
• Congenital abnormalities of the bile duct such as choledochal cyst

Diagnosis

Early diagnosis is not generally possible. People at high risk, such as women or Native Americans with gallstones, are evaluated closely. Transabdominal ultrasound, CT scan, endoscopic ultrasound, MRI, and MR cholangio-pancreatography (MRCP) may be used for diagnosis. A large number of gallbladder cancers are found incidentally in patients being evaluated for cholelithiasis or gallstone formation, which is far more common. A biopsy is the only certain way to tell whether or not the tumorous growth is malignant.

File:Gallbladder adenocarcinoma (3) lymphatic invasion histopathology.jpg|Gallbladder adenocarcinoma lymphatic invasion histopathology File:Gallbladder adenocarcinoma (1) histopathology.jpg|Incidentally discovered gallbladder cancer (adenocarcinoma) following a cholecystectomy. File:Gallbladder adenocarcinoma (2) histopathology.jpg|Gallbladder adenocarcinoma histopathology

Differential diagnosis

Xanthogranulomatous cholecystitis (XGC) is a rare form of gallbladder disease which mimics gallbladder cancer although it is not cancerous. It was first discovered and reported in the medical literature in 1976 by J.J. McCoy Jr., and colleagues.

Treatment

If the cancer is detected early, in a stage before has spread, it may be treatable by surgery. Gallbladder cancer surgery is called radical cholecystectomy or extended cholecystectomy and involves the removal of the gallbladder along with adequate removal of its liver bed to the healthy tissue. The lymph nodes in the vicinity of the cancer may also be removed. Sometimes removal of a large part of the liver called an hepatectomy is required to completely remove the tumor. The bile duct may also need to be removed. However, with gallbladder cancer's poor prognosis, most patients die within a year of surgery. If surgery is not possible, endoscopic stenting or percutaneous transhepatic biliary drainage (PTBD) of the biliary tree may reduce jaundice, and a stent in the stomach may relieve vomiting. Chemotherapy and radiation may also be used with surgery. If gallbladder cancer is diagnosed after cholecystectomy for stone disease (incidental cancer), re-operation to remove part of liver and lymph nodes is required in most cases. When it is done as early as possible, patients have the best chance of long-term survival and even cure.

Epidemiology

Most tumors are adenocarcinomas, with a small percent being squamous cell carcinomas.

• Gallbladder cancer is relatively rare, affecting fewer than 5000 people in the United States per year
• It is more common in South American countries, Japan, and Israel; in Chile, gallbladder cancer is the fourth most common cause of cancer deaths.
• It is the fifth most common gastrointestinal cancer
• It is up to five times more common in women than men depending on population (e.g. 73% female in China)
• The age adjusted incidence rates of gallbladder cancer is highest in Chile, followed by the state of Assam, India

Prognosis

The prognosis for gallbladder cancer is poor. The cancer commonly spreads to the liver, bile duct, stomach, and duodenum.

Research

A better understanding of the biology of biliary tract cancers, including gallbladder cancer, is being achieved by advances in genomic profiling. This research is providing insight into deficiencies in the tumor cell's ability to accurately repair damages in their own DNA. The tumors in about 25% of patients with biliary tract cancer have some form of DNA damage repair deficiency. Knowledge of such deficiencies can be exploited to potentially increase response to treatment strategies that are currently available such as chemotherapy, radiotherapy, or immunotherapy.

References

References

1. "Gallbladder cancer - Symptoms and causes".
2. "Risk Factors for Gallbladder Cancer".
3. "Types of gallbladder cancer | Gallbladder cancer | Cancer Research UK".
4. "Gallbladder cancer - Diagnosis and treatment - Mayo Clinic".
5. (25 June 2012). "Gallbladder Cancer - Statistics".
6. (2015). "Gallbladder Cancer Incidence and Mortality, United States 1999–2011". Cancer Epidemiology, Biomarkers & Prevention.
7. (2018-09-27). "CDC - Gallbladder Cancer Incidence and Death Rates". Cancer Epidemiology, Biomarkers & Prevention.
8. (2003). "Gallbladder cancer: an 'Indian' disease". Natl Med J India.
9. Fitzgerald, J Edward F. (Apr 2009). "Courvoisier's gallbladder: law or sign?". [[World Journal of Surgery]].
10. (February 2016). "Cancer Risk and Surveillance in Primary Sclerosing Cholangitis". Clinics in Liver Disease.
11. (2012). "Bacteria and Cancer".
12. Srivastava K, Srivastava A, Sharma KL, Mittal B. Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat Res. 2011 Jul–Oct;728(1–2):67–79.
13. "Gallbladder Cancer: Symptoms, Causes & Treatment {{!}} Dr. Nikhil Agrawal".
14. (2008-12-01). "Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)". Journal of Surgical Oncology.
15. "Tests for gallbladder cancer". Cancer Research UK.
16. (August 2009). "Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma with a false-positive result on fluorodeoxyglucose PET". World J. Gastroenterol..
17. (2005). "Xanthogranulomatous cholecystitis: differentiation from associated gall bladder carcinoma". Trop Gastroenterol.
18. (March 1976). "Xanthogranulomatous cholecystitis. Report of two cases". J S C Med Assoc.
19. "Cholecystectomy: Approaches and Technique".
20. (24 March 2004). "Gallbladder Cancer Treatment (PDQ®)–Patient Version".
21. (1995-01-01). "Liver, gallbladder, extrahepatic bile ducts, and pancreas". Cancer.
22. (December 2007). "Gallstones and the risk of biliary tract cancer: a population-based study in China". Br. J. Cancer.
23. National Cancer Registry Programme (2013).Three-year report of population based cancer registries:2009-2011. NCDIR-ICMR, Bangalore.
24. (21 November 2015). "Gallbladder carcinoma: Prognostic factors and therapeutic options". World Journal of Gastroenterology.
25. Lamarca A, Barriuso J, McNamara MG, Valle JW. Biliary Tract Cancer: State of the Art and potential role of DNA Damage Repair. Cancer Treat Rev. 2018 Nov;70:168-177. doi: 10.1016/j.ctrv.2018.09.002. Epub 2018 Sep 8. PMID 30218788